[144] UiPath, Inc. SEC Filing
Rhea-AI Filing Summary
UiPath, Inc. (PATH) filed a Form 144 reporting a proposed sale of 1,000,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of
Positive
- Sale size is modest at 1,000,000 shares (~0.22% of outstanding)
- Seller used Rule 10b5-1 program previously, showing pre-arranged trading activity
Negative
- Founder share sale could marginally increase free float and selling pressure around
10/06/2025
Insights
TL;DR: A founder sale under Rule 144 is planned and prior 10b5-1 sales were executed recently.
The filing records a proposed sale of
Compliance-wise, the notice includes the required representation that the seller is unaware of undisclosed material information and documents a history of Rule 10b5-1 sales in the prior three months. Watch for filings confirming execution details and any updates to the 10b5-1 plan timing within the next few trading days.
TL;DR: Sale size is modest relative to the share base but will increase circulating float slightly.
The proposed 1,000,000-share sale represents roughly 0.22% of the reported 453,568,899 shares outstanding, so the direct dilution or float increase is small in percentage terms. Prior 10b5-1 sales listed show repeated daily lots of 122,733 shares and blocks of 45,000 shares that have already generated multi-million dollar proceeds.
Investors may monitor short-term volume and any further insider dispositions; near-term impact is likely limited given the small percentage of outstanding shares, but execution timing could influence daily trading volumes around